Zobrazeno 1 - 10
of 68
pro vyhledávání: '"N J, Bundred"'
Publikováno v:
BMJ (Clinical research ed.). 378
Publikováno v:
Postgraduate Medical Journal. 71:28-31
Summary Hypercalcaemia associated with malignancy is generally thought to carry a poor prognosis. Of 47 consecutive patients with hypercalcaemia and malignancy, serum parathyroid hormone (PTH) was elevated in seven, consistent with co-existing hyperp
Publikováno v:
The Lancet. 339:164-167
Parathyroid-hormone-related protein (PTHrP) has been implicated as a humoral mediator of hypercalcaemia in malignant disease. We have investigated the contributions of PTHrP and parathyroid hormone (PTH) to the hypercalcaemia seen in routine clinical
Autor:
R. P. A’Hern, N. J. Bundred
Publikováno v:
Breast Cancer Online. 12
Use of perioperative anti-HER2 therapy presents an opportunity to use a therapy which has been shown to be effective in the adjuvant setting early in the course of a patient’s primary treatment, to assess tumour response in vivo using biomarkers an
Publikováno v:
BMJ. 303:1506-1509
OBJECTIVE--To see whether parathyroid hormone related protein has a humoral role in breast cancer. DESIGN--Plasma concentrations and tumour expression of parathyroid hormone related protein were determined (by two site immunoradiometric assay and imm
Autor:
N. J. Bundred, D. Everington, G. K. White, Helen J. Stewart, Rosemary A. Walker, William R. Miller
Publikováno v:
British Journal of Cancer
Apocrine differentiation in human breast cancers has been assessed using immunohistochemistry to detect zinc alpha 2 glycoprotein and the findings related to standard prognostic factors, disease free interval (DFI) and survival in 145 women with earl
Autor:
P, Kenemans, E, Kubista, J M, Foidart, C H, Yip, B, von Schoultz, P, Sismondi, R, Vassilopoulou-Sellin, M W, Beckmann, N J, Bundred, J, Egberts, S, van Os, J, Planellas
Publikováno v:
Breast (Edinburgh, Scotland). 16
Many patients with a history of breast cancer (BC) will suffer from vasomotor symptoms, which can be induced or exacerbated by treatment with tamoxifen or aromatase inhibitors. The LIBERATE trial was designed as a randomized, double-blind, multicente
Autor:
N. J. Bundred, N. L. P. Barnes
Publikováno v:
Breast Cancer Online. 8
The cyclooxygenase (COX) enzymes catalyse the rate-limiting step of conversion from arachidonic acid to prostaglandins (PGs). The enzyme exists in two isoforms COX-1 and COX-2. The inducible COX-2 isoform has been shown to be present in up to 80% of
Autor:
N J Bundred, A J Webb
Publikováno v:
British Journal of Surgery. 83:872-874
Publikováno v:
Postgraduate Medical Journal. 69:77-79
Summary We describe a case of hypercalcaemia secondary to recurrent malignant phaeochromocytoma. Parathyroid-related protein (PTHrp 1-86) immunoreactivity was identified in plasma and PTHrp was identified by immunocytochemistry in tumour tissue.